Secondaries Announced 3.8.18

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Global Blood Therapeutics
Symbol: GBT
Price: Last Trade $56.90
Trade Date: 3/9
Shares: 3.5 million
Re-Offer Range: Subscription Needed
Underwriter(s): Wells Fargo Securities
Description: They are a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities.
Rating = Subscription Needed

Company: VolitionRX Limited
Symbol: VNRX
Price: Last Trade $2.94
Trade Date: 3/9
Shares: 4.5 million ($10m-$12m cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s): Oppenheimer & Co.
Co-Manager(s): National Securities
Description: Volition is a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers.
Rating = Subscription Needed

Company: Advanced Disposal Services, Inc. – Block
Symbol: ADSW
Price: Last Trade $22.71
Trade Date: 3/9
Shares: 10 million
Re-Offer Range: Subscription Needed
Underwriter(s) : UBS
Description: Advanced Disposal brings fresh ideas and solutions to the business of a clean environment.
Rating = Subscription Needed

Company: Diplomat Pharmacy – Block
Symbol: DPLO
Price: Last Trade $21.35
Trade Date: 3/9
Shares: 2 million
Re-Offer Range: Subscription Needed
Underwriter(s): Morgan Stanley
Description: Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States.
Rating = Subscription Neededl